Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
APLT
Shares outstanding
143,223,667
Price per share
$0.10
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
58,883,039
Total reported value
$5,929,909
% of total 13F portfolios
0%
Share change
-35,826,681
Value change
-$23,764,068
Number of holders
50
Price from insider filings
$0.10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 15% +13% $12,946,856 +$1,644,911 21,403,300 +15% T. Rowe Price Investment Management, Inc. 30 Sep 2025
Alyeska Investment Group, L.P. 5.8% $2,615,924 6,707,497 Alyeska Investment Group, L.P. 31 Dec 2024
ALEXANDRIA REAL ESTATE EQUITIES, INC. 4.3% $1,755,000 6,500,000 Alexandria Real Estate Equities, Inc. 11 Dec 2025
Propel Bio Management, LLC 4.2% $1,564,002 6,015,394 Propel Bio Management, LLC 29 Dec 2025
Venrock Healthcare Capital Partners III, L.P. 4.1% -58% $2,171,407 -$2,432,661 5,567,709 -53% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
BlackRock, Inc. 3.7% -54% $1,003,183 -$783,523 5,219,475 -44% BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 3.3% -34% $1,473,225 -$359,492 4,734,013 -20% The Vanguard Group 30 Jun 2025
Schonfeld Strategic Advisors LLC 3.3% -53% $1,823,678 -$1,596,482 4,676,097 -47% Schonfeld Strategic Advisors LLC 31 Mar 2025
PERCEPTIVE ADVISORS LLC 2.4% $1,115,400 2,860,000 Perceptive Advisors LLC 31 Dec 2024
MORGAN STANLEY 2.5% -64% $1,114,983 -$2,323,072 2,858,931 -68% Morgan Stanley 31 Jan 2025
FRANKLIN RESOURCES INC 1.7% -70% $781,326 -$1,871,029 2,003,400 -71% Franklin Resources, Inc. 31 Dec 2024
JANUS HENDERSON GROUP PLC 0% -104% $13,958 -$4,706,957 35,791 -100% JANUS HENDERSON GROUP PLC 31 Dec 2024

As of 31 Dec 2025, 50 institutional investors reported holding 58,883,039 shares of Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT). This represents 41% of the company’s total 143,223,667 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) together control 40% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
T. Rowe Price Investment Management, Inc. 15% 21,747,844 +1.6% 0% $2,175,000
VANGUARD GROUP INC 4.4% 6,353,018 +25% 0% $635,302
Knoll Capital Management, LLC 4.2% 6,050,000 -22% 0.28% $605,000
DELTEC ASSET MANAGEMENT LLC 2.7% 3,847,449 0.06% $384,745
BlackRock, Inc. 2.3% 3,251,462 -15% 0% $325,146
RENAISSANCE TECHNOLOGIES LLC 1.9% 2,706,156 0% $270,616
Pathstone Holdings, LLC 1.8% 2,643,540 0% 0% $305,065
JANE STREET GROUP, LLC 1.5% 2,087,404 0% $208,740
GEODE CAPITAL MANAGEMENT, LLC 1% 1,492,903 +17% 0% $149,330
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.85% 1,211,629 -45% 0% $121,163
MILLENNIUM MANAGEMENT LLC 0.73% 1,051,846 -45% 0% $105,185
UBS Group AG 0.5% 718,924 -62% 0% $71,892
DEUTSCHE BANK AG\ 0.43% 622,226 0% 0% $62,223
Graham Capital Management, L.P. 0.4% 572,759 0% $57,276
STATE STREET CORP 0.39% 558,178 +7.6% 0% $55,818
Virtu Financial LLC 0.35% 496,288 +873% 0% $50,000
Lynx1 Capital Management LP 0.29% 410,500 0.01% $41,050
MARSHALL WACE, LLP 0.24% 337,389 -87% 0% $33,739
Hennion & Walsh Asset Management, Inc. 0.23% 327,137 +16% 0% $32,714
EQUITEC PROPRIETARY MARKETS, LLC 0.21% 300,600 0.14% $30,060
Bank of New York Mellon Corp 0.18% 253,573 +219% 0% $25,357
NORTHERN TRUST CORP 0.17% 245,144 +41% 0% $24,514
Rockefeller Capital Management L.P. 0.17% 241,897 -38% 0% $24,190
GTS SECURITIES LLC 0.14% 200,009 0% $20,001
MORGAN STANLEY 0.12% 178,474 -75% 0% $17,847

Institutional Holders of Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 58,883,039 $5,929,909 -$23,764,068 $0.10 50
2025 Q3 94,763,328 $57,199,408 +$5,274,176 $0.60 69
2025 Q2 88,058,885 $27,371,087 -$7,459,469 $0.31 72
2025 Q1 106,044,815 $51,845,704 -$6,334,916 $0.49 89
2024 Q4 115,065,005 $98,537,797 -$63,025,089 $0.86 116
2024 Q3 112,721,874 $960,819,113 +$78,176,113 $8.50 125
2024 Q2 103,226,978 $481,702,267 +$36,985,908 $4.67 92
2024 Q1 93,958,967 $638,614,949 +$241,302,453 $6.80 88
2023 Q4 61,449,532 $205,844,085 +$29,840,415 $3.35 83
2023 Q3 42,970,428 $106,996,842 +$29,101,733 $2.49 54
2023 Q2 31,465,661 $40,275,555 +$15,796,729 $1.28 38
2023 Q1 19,276,965 $15,634,509 -$232,317 $0.81 34
2022 Q4 19,679,561 $15,064,959 -$2,201,503 $0.76 37
2022 Q3 22,671,560 $21,085,673 -$3,749,758 $0.93 38
2022 Q2 26,706,667 $25,318,845 +$12,989,524 $0.95 46
2022 Q1 12,347,239 $26,037,310 -$34,487,329 $2.11 68
2021 Q4 14,922,342 $133,548,279 -$7,772,547 $8.95 67
2021 Q3 15,108,904 $250,903,236 -$6,255,939 $16.60 66
2021 Q2 15,367,633 $319,342,764 +$10,194,603 $20.78 68
2021 Q1 14,854,223 $278,593,752 +$51,374,327 $18.76 66
2020 Q4 12,104,777 $266,428,658 -$1,610,604 $22.01 67
2020 Q3 12,195,771 $253,182,315 -$6,258,655 $20.76 66
2020 Q2 11,427,491 $412,583,649 +$78,213,106 $36.15 71
2020 Q1 9,645,977 $315,329,165 +$155,281,170 $32.69 62
2019 Q4 4,991,742 $136,175,281 +$71,201,517 $27.28 45
2019 Q3 2,395,520 $26,326,659 +$2,265,568 $10.99 29
2019 Q2 2,195,975 $18,095,000 +$18,095,000 $8.24 13